Monoclonal Antibody Treatments for COVID-19 (Bamlanivimab and Regeneron): The linked letter and referral form below are intended to provide updated information regarding the referral process and available Maryland infusion sites for the two FDA EUA-approved monoclonal antibody (mAb) treatments for COVID-19: bamlanivimab (Eli Lilly) and the antibody combination, casirivimab/imdevimab (Regeneron). Early data for these therapeutics suggest that they may reduce the risk of hospitalization for people at high risk who have tested positive for COVID-19 and have only mild to moderate symptoms.
The Centers for Disease Control and Prevention (CDC) and state public health authorities are investigating confirmed and probable cases of monkeypox (in the orthopoxvirus genus) throughout multiple states. Click here to learn more. The Frederick County Health Department is monitoring the emerging public health issue and taking action for local public health preparedness.